Literature DB >> 26992778

Molecular insights on the effect of TGF-β1/-β3 in human corneal fibroblasts.

Xiaoqing Guo1, Audrey E K Hutcheon2, James D Zieske3.   

Abstract

Transforming growth factor β (TGF-β) plays a critical role in wound healing and the pathogenesis of fibrosis (scarring). Three isoforms of TGF-β have been identified in mammals. Previous studies have shown that the addition of TGF-β1 (T1) or -β2 (T2) to human corneal fibroblasts (HCF) cultured in a 3-dimensional construct resulted in a fibrotic matrix, while the addition of TGF-β3 (T3) resulted in the production of enhanced non-fibrotic matrix as compared to control (Vitamin C [VitC] only). In the current investigation, we undertook the molecular comparison of fibrosis-related gene expression in T1 or T3-treated HCF to gain further insights into the regulation and roles of these two isoforms on the fibrotic response. HCF were cultured in 100 mm dishes in basic medium (Eagles minimum essential medium [EMEM] with 10% fetal bovine serum [FBS]). At 70-80% confluency, cells were exposed to basic medium with 0.5 mM 2-O-α-d-glucopyranosyl-l-ascorbic acid (VitC) ± 2 ng/ml of T1 or T3. After 4 h or 3 days, cells were harvested, and mRNA or protein was isolated. Fibrosis related mRNA levels were assayed using a commercial qRT-PCR Array. Selected proteins were examined using Western blotting (WB). Experiments were performed 6 times for the qRT-PCR and 4 times for WB for each condition. qRT-PCR results showed that most of the fibrosis-related genes were up or downregulated in HCF exposed to T1 or T3 as compared with VitC control. At 4 h, only Smad7 expression was significantly altered in T3-treated HCF, compared to T1, and at 3 days, five genes were altered. WB confirmed that T1 significantly decreased Smad7 expression compared to T3 and control, and that the expression of thrombospondin-1 in T3-stimulated HCF was enhanced compared to T1-treated cells. Finally, both T1 and T3 decreased Smad3 expression dramatically at both time points. At early time points, T1 and T3 have similar effects on expression of fibrosis related genes; however, with a longer exposure, an increasing number of genes were differentially expressed. Interestingly, most of the differentially expressed gene products are secreted by the cells and may be related to the modulation of extracellular matrix.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fibrosis; Gene array; Human corneal fibroblasts; Smad3; Smad7; TGF-beta1; TGF-beta3; Thrombospondin-1

Mesh:

Substances:

Year:  2016        PMID: 26992778      PMCID: PMC4893894          DOI: 10.1016/j.exer.2016.03.011

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  56 in total

1.  Identification of apoptotic genes mediating TGF-beta/Smad3-induced cell death in intestinal epithelial cells using a genomic approach.

Authors:  Yanna Cao; Lu Chen; Weili Zhang; Yan Liu; Harry T Papaconstantinou; Craig R Bush; Courtney M Townsend; E Aubrey Thompson; Tien C Ko
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-08-10       Impact factor: 4.052

2.  Avotermin for scar improvement following scar revision surgery: a randomized, double-blind, within-patient, placebo-controlled, phase II clinical trial.

Authors:  Karen So; Duncan A McGrouther; James A Bush; Piyush Durani; Lisa Taylor; Gaynor Skotny; Tracey Mason; Anthony Metcalfe; Sharon O'kane; Mark W J Ferguson
Journal:  Plast Reconstr Surg       Date:  2011-07       Impact factor: 4.730

Review 3.  Corneal stromal wound healing in refractive surgery: the role of myofibroblasts.

Authors:  J V Jester; W M Petroll; H D Cavanagh
Journal:  Prog Retin Eye Res       Date:  1999-05       Impact factor: 21.198

4.  Influence of exogenous TGFbeta1 on the expression of smad2 and smad3 in rat bone marrow-derived mesenchymal stem cells.

Authors:  Yuntao Wang; Qixin Zheng; Xiaodong Guo; Yongchao Wu; Jie Hao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

5.  Cell phenotype-specific down-regulation of Smad3 involves decreased gene activation as well as protein degradation.

Authors:  Anne-Christine Poncelet; H William Schnaper; Ruoyun Tan; Youhua Liu; Constance E Runyan
Journal:  J Biol Chem       Date:  2007-03-30       Impact factor: 5.157

Review 6.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

7.  Role of thrombospondin-1 in repair of penetrating corneal wounds.

Authors:  José Tomás Blanco-Mezquita; Audrey E K Hutcheon; James D Zieske
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-17       Impact factor: 4.799

Review 8.  TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring.

Authors:  Kenneth R Cutroneo
Journal:  Wound Repair Regen       Date:  2007 Sep-Oct       Impact factor: 3.617

9.  Protection of cerulein-induced pancreatic fibrosis by pancreas-specific expression of Smad7.

Authors:  Jing He; Xiaolan Sun; Ke-Qing Qian; Xubao Liu; Zhenzhen Wang; Yan Chen
Journal:  Biochim Biophys Acta       Date:  2008-10-30

Review 10.  Dynamics of Transforming Growth Factor Beta Signaling in Wound Healing and Scarring.

Authors:  Kenneth W Finnson; Sarah McLean; Gianni M Di Guglielmo; Anie Philip
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-06       Impact factor: 4.730

View more
  20 in total

Review 1.  Corneal injury: Clinical and molecular aspects.

Authors:  Brayden Barrientez; Sarah E Nicholas; Amy Whelchel; Rabab Sharif; Jesper Hjortdal; Dimitrios Karamichos
Journal:  Exp Eye Res       Date:  2019-06-22       Impact factor: 3.467

2.  Hepatitis C virus-induced tumor-initiating cancer stem-like cells activate stromal fibroblasts in a xenograft tumor model.

Authors:  Reina Sasaki; Pradip Devhare; Ratna B Ray; Ranjit Ray
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

3.  Development of wound healing models to study TGFβ3's effect on SMA.

Authors:  Sriniwas Sriram; Jennifer A Tran; Xiaoqing Guo; Audrey E K Hutcheon; Andrius Kazlauskas; James D Zieske
Journal:  Exp Eye Res       Date:  2017-06-06       Impact factor: 3.467

4.  P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.

Authors:  Fang-Fang Duan; Gabriel Barron; Angelo Meliton; Gokhan M Mutlu; Nickolai O Dulin; Lucia Schuger
Journal:  Am J Respir Cell Mol Biol       Date:  2019-02       Impact factor: 6.914

Review 5.  Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.

Authors:  Daisy Y Shu; Frank J Lovicu
Journal:  Prog Retin Eye Res       Date:  2017-08-12       Impact factor: 21.198

6.  Neuronal Protein 3.1 Deficiency Leads to Reduced Cutaneous Scar Collagen Deposition and Tensile Strength due to Impaired Transforming Growth Factor-β1 to -β3 Translation.

Authors:  Tao Cheng; Michael Yue; Muhammad Nadeem Aslam; Xin Wang; Gajendra Shekhawat; James Varani; Lucia Schuger
Journal:  Am J Pathol       Date:  2016-12-08       Impact factor: 4.307

7.  SMAD3 expression and regulation of fibroplasia in vocal fold injury.

Authors:  Nao Hiwatashi; Peter A Benedict; Gregory R Dion; Renjie Bing; Iv Kraja; Milan R Amin; Ryan C Branski
Journal:  Laryngoscope       Date:  2017-05-20       Impact factor: 3.325

8.  TGF-β-target genes are differentially regulated in corneal epithelial cells and fibroblasts.

Authors:  Xiaoqing Guo; Audrey E K Hutcheon; Jennifer A Tran; James D Zieske
Journal:  New Front Ophthalmol       Date:  2017-01-30

Review 9.  Corneal pain and experimental model development.

Authors:  Tina B McKay; Yashar Seyed-Razavi; Chiara E Ghezzi; Gabriela Dieckmann; Thomas J F Nieland; Dana M Cairns; Rachel E Pollard; Pedram Hamrah; David L Kaplan
Journal:  Prog Retin Eye Res       Date:  2018-11-16       Impact factor: 21.198

10.  Fibroblastic and bone marrow-derived cellularity in the corneal stroma.

Authors:  Steven E Wilson; Lycia Pedral Sampaio; Thomas Michael Shiju; Rodrigo Carlos de Oliveira
Journal:  Exp Eye Res       Date:  2020-10-14       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.